Opinion

Video

Impact of Comorbidities on IPF Management

Key Takeaways

  • Comorbidities can obscure IPF symptoms, leading to diagnostic delays or misdiagnoses, complicating the clinical presentation.
  • Comprehensive evaluation is crucial to tailor treatment plans addressing both IPF and comorbidities effectively.
SHOW MORE

Toby Maher, MD, PhD, discusses how comorbidities complicate the diagnosis and management of idiopathic pulmonary fibrosis (IPF) and influence treatment decisions, highlighting the need for a comprehensive approach in patient care.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
5 experts are featured in this series
5 experts are featured in this series
Dr Brian Slomovitz
Dr Sheela Rao
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo